HUP0105173A2 - Adagolási módszer és készítmény sürgősségi fogamzásgátlásra - Google Patents

Adagolási módszer és készítmény sürgősségi fogamzásgátlásra

Info

Publication number
HUP0105173A2
HUP0105173A2 HU0105173A HUP0105173A HUP0105173A2 HU P0105173 A2 HUP0105173 A2 HU P0105173A2 HU 0105173 A HU0105173 A HU 0105173A HU P0105173 A HUP0105173 A HU P0105173A HU P0105173 A2 HUP0105173 A2 HU P0105173A2
Authority
HU
Hungary
Prior art keywords
preparations
emergency contraception
active ingredient
pharmaceutical composition
dosage regimen
Prior art date
Application number
HU0105173A
Other languages
English (en)
Inventor
Illésné Balogh
Katalin Komándi
Paul Look
László Nemes
Zsolt Szabó
Original Assignee
Richter Gedeon Vegyészeti Gyár Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyészeti Gyár Rt. filed Critical Richter Gedeon Vegyészeti Gyár Rt.
Priority to HU0105173A priority Critical patent/HU227198B1/hu
Publication of HUP0105173D0 publication Critical patent/HUP0105173D0/hu
Priority to AU2002347401A priority patent/AU2002347401A1/en
Priority to NZ530056A priority patent/NZ530056A/en
Priority to OA1200400148A priority patent/OA12730A/fr
Priority to YUP-42/04A priority patent/RS50768B/sr
Priority to DK02783334T priority patent/DK1448207T3/da
Priority to EA200400731A priority patent/EA006545B1/ru
Priority to BR0210595-0A priority patent/BR0210595A/pt
Priority to CNA028137523A priority patent/CN1551774A/zh
Priority to PL369520A priority patent/PL206010B1/pl
Priority to AT02783334T priority patent/ATE293978T1/de
Priority to ES02783334T priority patent/ES2239727T3/es
Priority to SI200230132T priority patent/SI1448207T1/xx
Priority to PT02783334T priority patent/PT1448207E/pt
Priority to MXPA04005104A priority patent/MXPA04005104A/es
Priority to IL15939402A priority patent/IL159394A0/xx
Priority to PCT/HU2002/000129 priority patent/WO2003045397A1/en
Priority to KR1020047002069A priority patent/KR100908161B1/ko
Priority to APAP/P/2004/003046A priority patent/AP1849A/en
Priority to JP2003546899A priority patent/JP2005516904A/ja
Priority to CA2450359A priority patent/CA2450359C/en
Priority to UA20040504015A priority patent/UA79942C2/uk
Priority to EP02783334A priority patent/EP1448207B1/en
Priority to GE5567A priority patent/GEP20063882B/en
Priority to DE60203929T priority patent/DE60203929T2/de
Publication of HUP0105173A2 publication Critical patent/HUP0105173A2/hu
Priority to IS7065A priority patent/IS2691B/is
Priority to TNP2004000048A priority patent/TNSN04048A1/en
Publication of HUP0105173A3 publication Critical patent/HUP0105173A3/hu
Priority to NO20041607A priority patent/NO333984B1/no
Priority to MA27643A priority patent/MA27076A1/fr
Priority to ZA2004/04114A priority patent/ZA200404114B/en
Priority to HR20040584 priority patent/HRP20040584B1/xx
Priority to EC2004005171A priority patent/ECSP045171A/es
Priority to US10/495,923 priority patent/US20050288264A2/en
Publication of HU227198B1 publication Critical patent/HU227198B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

A találmány tárgyát sürgősségi fogamzásgátlásra szolgáló adagolásimódszer, az erre a célra való készítmények, a levonorgesztrel ilyencélra szolgáló készítmények előállítására történő alkalmazása,valamint az ilyen célra szolgáló készítmények előállítási eljárásaképezi. A levonorgesztrel hatóanyaggal végzett találmány szerintisürgősségi fogamzásgátlásra az jellemző, hogy a hatóanyag-bevitel akoituszt követő 72 órán belül egyetlen, 1,5 < 0,2 mg levonorgesztrelhatóanyagot tartalmazó adagolási egység beadásával történik. Atalálmány szerinti készítmények adagolási egységenként hatóanyagkéntcsak 1,5 < 0,2 mg levonorgesztrelt tartalmaznak a gyógyászatikészítmények előállításánál szokásos töltő, hígító, íz- és illatadó,stabilizáló és a formulázást megkönnyítő segéd- és adalékanyagokmellett. Ó
HU0105173A 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel HU227198B1 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
DE60203929T DE60203929T2 (de) 2001-11-27 2002-11-26 Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung
PCT/HU2002/000129 WO2003045397A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception
APAP/P/2004/003046A AP1849A (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception
OA1200400148A OA12730A (fr) 2001-11-27 2002-11-26 Régime de dosage et composition pharmaceutique pour contraception d'urgence.
NZ530056A NZ530056A (en) 2001-11-27 2002-11-26 Single administration of 1.5 mg levonorgestrel increases compliance and decreases possibility of incorrect use of this post-coital contraceptive
DK02783334T DK1448207T3 (da) 2001-11-27 2002-11-26 Doseringsplan og farmaceutisk sammensætning af nödprævention
JP2003546899A JP2005516904A (ja) 2001-11-27 2002-11-26 緊急避妊のための薬学的組成物およびその用量処方
BR0210595-0A BR0210595A (pt) 2001-11-27 2002-11-26 Regime de dosagem e composição farmacêutica para contracepção de emergência
CNA028137523A CN1551774A (zh) 2001-11-27 2002-11-26 紧急避孕药物剂量方案和药物组合物
PL369520A PL206010B1 (pl) 2001-11-27 2002-11-26 Środek farmaceutyczny do antykoncepcji doraźnej zawierający lewonorgestrel i zastosowanie lewonorgestrelu
AT02783334T ATE293978T1 (de) 2001-11-27 2002-11-26 Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung
ES02783334T ES2239727T3 (es) 2001-11-27 2002-11-26 Regimen de dosificacion y composicion farmaceutica para anticoncepcion de emergencia.
SI200230132T SI1448207T1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception
PT02783334T PT1448207E (pt) 2001-11-27 2002-11-26 Composicao farmaceutica e regime de dosagem para a contracepcao de emergencia
MXPA04005104A MXPA04005104A (es) 2001-11-27 2002-11-26 Regimen de dosificacion y composicion farmaceutica para anticoncepcion de emergencia.
IL15939402A IL159394A0 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception
AU2002347401A AU2002347401A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception
KR1020047002069A KR100908161B1 (ko) 2001-11-27 2002-11-26 응급피임용 투약방법 및 약제학적 조성물
YUP-42/04A RS50768B (sr) 2001-11-27 2002-11-26 Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
EA200400731A EA006545B1 (ru) 2001-11-27 2002-11-26 Единичная дозированная форма фармацевтической композиции для экстренной контрацепции и способы её получения и применения
CA2450359A CA2450359C (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception
UA20040504015A UA79942C2 (en) 2001-11-27 2002-11-26 Levonorgestrel pharmaceutical composition and use thereof for emergency contraception
EP02783334A EP1448207B1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception
GE5567A GEP20063882B (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception
IS7065A IS2691B (is) 2001-11-27 2003-12-05 Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð
TNP2004000048A TNSN04048A1 (en) 2001-11-27 2004-03-26 Dosage regimen and pharmaceutical composition for emergency contraception
NO20041607A NO333984B1 (no) 2001-11-27 2004-04-20 Farmasøytisk preparat for nødprevensjon og anvendelse derav.
MA27643A MA27076A1 (fr) 2001-11-27 2004-04-21 Regime de dosage et composition pharmaceutique pour contraception d'urgence
ZA2004/04114A ZA200404114B (en) 2001-11-27 2004-05-26 Dosage regimen and pharmaceutical composition for emergency contraception
HR20040584 HRP20040584B1 (en) 2001-11-27 2004-06-24 Dosage regimen and pharmaceutical composition for emergency contraception
EC2004005171A ECSP045171A (es) 2001-11-27 2004-06-25 Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia
US10/495,923 US20050288264A2 (en) 2001-11-27 2004-10-05 Dosage Regimen and Pharmaceutical Composition for Emergency Contraception

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel

Publications (4)

Publication Number Publication Date
HUP0105173D0 HUP0105173D0 (en) 2002-02-28
HUP0105173A2 true HUP0105173A2 (hu) 2003-08-28
HUP0105173A3 HUP0105173A3 (en) 2004-03-29
HU227198B1 HU227198B1 (en) 2010-10-28

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel

Country Status (33)

Country Link
US (1) US20050288264A2 (hu)
EP (1) EP1448207B1 (hu)
JP (1) JP2005516904A (hu)
KR (1) KR100908161B1 (hu)
CN (1) CN1551774A (hu)
AP (1) AP1849A (hu)
AT (1) ATE293978T1 (hu)
AU (1) AU2002347401A1 (hu)
BR (1) BR0210595A (hu)
CA (1) CA2450359C (hu)
DE (1) DE60203929T2 (hu)
DK (1) DK1448207T3 (hu)
EA (1) EA006545B1 (hu)
EC (1) ECSP045171A (hu)
ES (1) ES2239727T3 (hu)
GE (1) GEP20063882B (hu)
HR (1) HRP20040584B1 (hu)
HU (1) HU227198B1 (hu)
IL (1) IL159394A0 (hu)
IS (1) IS2691B (hu)
MA (1) MA27076A1 (hu)
MX (1) MXPA04005104A (hu)
NO (1) NO333984B1 (hu)
NZ (1) NZ530056A (hu)
OA (1) OA12730A (hu)
PL (1) PL206010B1 (hu)
PT (1) PT1448207E (hu)
RS (1) RS50768B (hu)
SI (1) SI1448207T1 (hu)
TN (1) TNSN04048A1 (hu)
UA (1) UA79942C2 (hu)
WO (1) WO2003045397A1 (hu)
ZA (1) ZA200404114B (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0719486A2 (pt) * 2006-12-20 2014-02-18 Duramed Pharmaceuticals Inc "forma farmacêutica sólida oral desitegrante, não-efervescente, métodos para tratar uma mulher que necessite de um contraceptivo de emergência, pacote terapêutico para tratar uma mulher que necessite de contracepção de emergência e processo para a preparação de uma forma sólida de dosagem farmacêutica oral desintegrante, não-efervescente"
EP2234491A4 (en) * 2007-12-20 2010-12-22 Teva Womens Health Inc DOSAGE SCHEMES AND PHARMACEUTICAL COMPOSITIONS AND PACKAGING FOR EMERGENCY CONTRACEPTION
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
US9180131B2 (en) 2008-12-12 2015-11-10 Laboratoire Hra Pharma Method for contraception
ME02548B (me) 2009-04-14 2017-02-20 Hra Pharma Lab Postupak za kontracepciju po potrebi
PE20120860A1 (es) * 2009-06-23 2012-07-15 Bayer Ip Gmbh Combinacion farmaceutica que comprende levonorgestrel en combinacion con piroxicam, indometacina o diclofenaco
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
SG195118A1 (en) 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
WO2012164095A1 (en) 2011-06-01 2012-12-06 Estetra S.A. Process for the production of estetrol intermediates
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
PL2741824T3 (pl) * 2011-08-11 2018-03-30 Estetra S.P.R.L. Zastosowanie estetrolu jako środka antykoncepcji awaryjnej
KR20150085512A (ko) 2012-11-22 2015-07-23 바이엘 파마 악티엔게젤샤프트 필요시 피임을 위한 레보노르게스트렐 및 cox 억제제 함유 제약 조성물의 용도 및 적용 요법
JP6370887B2 (ja) 2013-05-23 2018-08-08 バイエル・ファルマ・アクティエンゲゼルシャフト オンデマンド避妊のための医薬組成物およびその使用、ならびにこの医薬組成物の適用体制
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
US10894014B2 (en) 2015-06-18 2021-01-19 Estetra Sprl Orodispersible tablet containing Estetrol
SI3310346T1 (sl) 2015-06-18 2021-07-30 Estetra Sprl Orodisperzibilna tableta, ki vsebuje estetrol
PE20231714A1 (es) 2015-06-18 2023-10-23 Estetra Sprl Unidad de dosificacion orodispersable que contiene un componente estetrol
UA123098C2 (uk) 2015-06-18 2021-02-17 Естетра Спрл Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
US20230338355A1 (en) * 2020-07-30 2023-10-26 Acer Therapeutics Inc. Nk antagonists for contraception

Also Published As

Publication number Publication date
MXPA04005104A (es) 2004-08-19
HUP0105173D0 (en) 2002-02-28
KR20040066088A (ko) 2004-07-23
RS50768B (sr) 2010-08-31
AU2002347401A1 (en) 2003-06-10
TNSN04048A1 (en) 2006-06-01
SI1448207T1 (en) 2005-10-31
NO20041607L (no) 2004-04-20
HRP20040584B1 (en) 2012-11-30
ES2239727T3 (es) 2005-10-01
OA12730A (fr) 2006-06-28
US20050288264A2 (en) 2005-12-29
IL159394A0 (en) 2004-06-01
EP1448207B1 (en) 2005-04-27
PL206010B1 (pl) 2010-06-30
IS2691B (is) 2010-10-15
PT1448207E (pt) 2005-08-31
NZ530056A (en) 2005-02-25
ZA200404114B (en) 2005-10-26
HUP0105173A3 (en) 2004-03-29
AP2004003046A0 (en) 2004-06-30
CN1551774A (zh) 2004-12-01
PL369520A1 (en) 2005-04-18
US20050032755A1 (en) 2005-02-10
EA200400731A1 (ru) 2004-12-30
CA2450359C (en) 2011-05-10
ATE293978T1 (de) 2005-05-15
KR100908161B1 (ko) 2009-07-16
UA79942C2 (en) 2007-08-10
AP1849A (en) 2008-05-23
MA27076A1 (fr) 2004-12-20
IS7065A (is) 2003-12-05
CA2450359A1 (en) 2003-06-05
DK1448207T3 (da) 2005-06-27
HRP20040584A2 (en) 2005-02-28
BR0210595A (pt) 2004-06-08
NO333984B1 (no) 2013-11-04
GEP20063882B (en) 2006-07-25
HU227198B1 (en) 2010-10-28
DE60203929D1 (de) 2005-06-02
EP1448207A1 (en) 2004-08-25
RS4204A (en) 2007-02-05
ECSP045171A (es) 2004-08-27
DE60203929T2 (de) 2006-01-19
EA006545B1 (ru) 2006-02-24
JP2005516904A (ja) 2005-06-09
WO2003045397A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
HUP0105173A2 (hu) Adagolási módszer és készítmény sürgősségi fogamzásgátlásra
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer&#39;s disease
CO5060477A1 (es) Forma de dosificacion de nefazodona
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
HUP0401195A2 (hu) Averziót okozó szert tartalmazó készítmények opioidokkal való visszaélés megakadályozására
JP2005516904A5 (hu)
DE60121301D1 (de) Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen
ATE353009T1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
BR0210261A (pt) Formulações farmacêuticas para a administração eficiente de apomorfina, 6ar-(-)-n-propil-norapomorfina e seus derivados e pró-drogas destes
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
BR0115985A (pt) Preparação farmacêutica em forma de uma pasta compreendendo um ingrediente ativo ácido-lábil
AP2003002763A0 (en) Controlled release formulations for oral administration
KR880007073A (ko) 의 약 품
ES2175663T3 (es) Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis.
MXPA05005781A (es) Combinacion de ibuprofeno y oxicodona para alivio de dolor agudo.
MXPA05013270A (es) Forma de administracion transmucosal con irritacion mucosal reducida. reducida.
RU2604576C1 (ru) Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения
Sekar et al. Characterization and Formulation of Miswak Film for the Treatment of Chronic Periodontitis: An: In Vitro: Study
JPS6315245B2 (hu)
KR102213669B1 (ko) 카페인 가용화 조성물
JPS6360926A (ja) 感冒薬
JPH07116039B2 (ja) 安定な塩酸トリメトキノール内用液剤
AU2019203288A1 (en) Process for preparing pharmaceutical compositions resulting in reduction in overall fill volume for use with soft gelatin formulations
JPH0959149A (ja) 消炎鎮痛組成物

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: RICHTER GEDEON NYRT., HU

Free format text: FORMER OWNER(S): RICHTER GEDEON VEGYESZETI GYAR RT., HU